Pleural mesothelioma mimics the integrin profile of activated, sessile rather than detached mesothelial cells

Int J Cancer. 1997 Jul 3;72(1):77-86. doi: 10.1002/(sici)1097-0215(19970703)72:1<77::aid-ijc12>3.0.co;2-7.

Abstract

Mesothelial cells (MC) form a polarized monolayer lining serosal cavities. During serositis, the MC lining undergoes hyperplasia, and MC are shed into effusions. During these processes, contact with basement membrane and, ultimately, neighboring cells is at least temporarily lost, suggesting regulated alterations in cell/matrix and cell/cell adhesion. Such interactions are primarily mediated by integrins. Malignant mesothelioma has a growth pattern characterized by lateral, limited invasive but contiguous spread. During serositis, activated MC, both sessile and detached, expressed an extended spectrum of beta1, beta3 and beta4 integrins compared with resting MC, as shown by immunohistology. Malignant mesothelioma had an integrin repertoire and a subcellular distribution resembling that of activated sessile rather than floating MC. In vitro, MC exposed a more comprehensive pattern of integrins than that of the newly established mesothelioma cell lines ME-HD-1 and ME-HD-2, as shown by flow cytometry. MC consistently adhered better than mesothelioma cells to laminin, tenascin, fibronectin and collagen type IV. Adhesion of MC and mesothelioma cells to these matrix proteins was, at least in part, mediated via beta1 integrins. The different integrin profiles and adhesion properties of cultured MC and mesothelioma cells may reflect a limited functional differentiation of the latter.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal
  • Cells, Cultured
  • Epithelium / metabolism
  • Flow Cytometry
  • Humans
  • Immunohistochemistry
  • Integrin beta1 / metabolism
  • Integrins / metabolism*
  • Mesothelioma / metabolism*
  • Pleural Neoplasms / metabolism*
  • Serositis / metabolism
  • Tumor Cells, Cultured

Substances

  • Antibodies, Monoclonal
  • Integrin beta1
  • Integrins